{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:54:37Z","timestamp":1762955677071,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["503\/8- 000-01\/503-81-002"],"award-info":[{"award-number":["503\/8- 000-01\/503-81-002"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11926-017-0646-8","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T02:12:24Z","timestamp":1490839944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis\u2014Are We Getting Closer to Personalised Medicine?"],"prefix":"10.1007","volume":"19","author":[{"given":"Justyna","family":"Roszkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"646_CR1","doi-asserted-by":"crossref","unstructured":"Fragoulakis V, Mitropoulou C, Williams M, Patrinos G (2015) Economic evaluation in genomic medicine. Academic Press, p. 27\u201334","DOI":"10.1016\/B978-0-12-801497-4.00003-5"},{"key":"646_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"issue":"16","key":"646_CR3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A. \u2013 U.S.R.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group. N Engl J Med. 1992;326(16):1043\u20139.","journal-title":"N Engl J Med"},{"key":"646_CR4","first-page":"16","volume":"124","author":"ME Weinblatt","year":"2013","unstructured":"Weinblatt ME. Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc. 2013;124:16\u201325.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"646_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00052","author":"S Pastore","year":"2015","unstructured":"Pastore S, Stocco G, Favretto D, De Ludicibus S, Taddio A. Genetic determinants for methotrexate response in juvenile idiopathic arthritis. Front Pharmacol. 2015. doi: 10.3389\/fphar.2015.00052 .","journal-title":"Front Pharmacol"},{"key":"646_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/187152811304140915152102","volume":"13","author":"P Joshi","year":"2014","unstructured":"Joshi P, Dhaneshwar SS. An update on disease modifying antirheumatic drugs. Inflamm Allergy Drug Targets. 2014;13:249\u201361.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"646_CR7","first-page":"102","volume":"28","author":"SL Morgan","year":"2010","unstructured":"Morgan SL, Baggott JE. Folate supplementation during methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol. 2010;28:102\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"646_CR8","doi-asserted-by":"crossref","unstructured":"Dervieux T, Kremer J, Lein DO, Capps R, Barham R. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglumate levels in patients with rheumatoid arthritis. Pharmacogenetics. 2004;14(11):733\u20139.","DOI":"10.1097\/00008571-200411000-00004"},{"issue":"4","key":"646_CR9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/tpj.2014.3","volume":"14","author":"J Cobb","year":"2015","unstructured":"\u2022\u2022 Cobb J, Cule E, Moncrieffe H, Hinks A, Ursu S, et al. Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. Pharmacogenomics J. 2015;14(4):356\u201364. This is the first study on this topic performed by genome-wide association study method. What is more, the results show the correlation between the polymorphism of genes from outside of MTX metabolic pathway and its efficacy.","journal-title":"Pharmacogenomics J"},{"key":"646_CR10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2010.146191","volume":"70","author":"A Hinks","year":"2011","unstructured":"Hinks A, Moncrieffe H, Martin P, Ursu S, Lal S, et al. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Ann Rheum Dis. 2011;70:1395\u2013400.","journal-title":"Ann Rheum Dis"},{"key":"646_CR11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00296-014-3131-y","volume":"35","author":"S Pastore","year":"2015","unstructured":"Pastore S, Stocco G, Moressa V, Zandona L, Favretto D, et al. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphatate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatol Int. 2015;35:619\u201327.","journal-title":"Rheumatol Int"},{"key":"646_CR12","first-page":"1832","volume":"32","author":"H Schmeling","year":"2005","unstructured":"Schmeling H, Biber D, Heins S, Horneff G. Influence of methylenrtetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol. 2005;32:1832\u20136.","journal-title":"J Rheumatol"},{"key":"646_CR13","doi-asserted-by":"crossref","unstructured":"Moya P, Salazar J, Arranz MJ, Diaz-Torne C, del Rio E, et al. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. Pharmacogenomics. 2016;17(1):25\u20139.","DOI":"10.2217\/pgs.15.150"},{"key":"646_CR14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.27434","volume":"62","author":"ML Becker","year":"2010","unstructured":"Becker ML, van Haandel L, Gaedigk R, Lasky A, Hoetzel M, et al. Analysis of intracellular methotrexate polyglumates in patients with juvenile idiopathic arthritis. Effect of route of administration on variability in intracellular methotrexate polyglumate concentration. Arthritis Rheum. 2010;62:1803\u201312.","journal-title":"Arthritis Rheum"},{"key":"646_CR15","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3899\/jrheum.091427","volume":"37","author":"J Tukova","year":"2010","unstructured":"Tukova J, Chladek J, Hroch M, Nemcova D, Hoza J, et al. 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates and MTHFR polymorphisms. J Rheumatol. 2010;37:2180\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"646_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.2010.03814.x","volume":"71","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, et al. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Br J Clin Pharmacol. 2011;71(2):237\u201343.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"646_CR17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrrheum.2014.140","volume":"10","author":"H Schmeling","year":"2014","unstructured":"Schmeling H, Horneff G, Benseler SM, Fritzler MJ, et al. Pharmacogenetics: can genes determine treatment efficacy and safety in JIA? Nat Rev Rheumatol. 2014;10(11):682\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"646_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2013.10.029","volume":"164","author":"PJ Hashkes","year":"2013","unstructured":"Hashkes PJ, Becker ML, Cabral DA, Laxer RM, Paller AS. Methotrexate: new uses for an old drug. J Pediatr. 2013;164:231\u20136.","journal-title":"J Pediatr"},{"key":"646_CR19","doi-asserted-by":"crossref","unstructured":"Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J. 2013;13(3):227\u201334.","DOI":"10.1038\/tpj.2012.7"},{"key":"646_CR20","doi-asserted-by":"crossref","unstructured":"Chan ES, Cronstein BN. Methotrexate\u2014how does it really work? Nat Rev Rheumatol. 2010;6:175\u20138.","DOI":"10.1038\/nrrheum.2010.5"},{"key":"646_CR21","doi-asserted-by":"crossref","unstructured":"van de Ven R, Oerlemans R, van der Heijden JW, Scheffler GL, De Grunji TD, et al. ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol. 2009;86:1075\u201387.","DOI":"10.1189\/jlb.0309147"},{"key":"646_CR22","doi-asserted-by":"crossref","unstructured":"de Graf D, Sharma RC, Mechetner EB, Schimke RT, Roninson IB. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc Natl Acad Sci. 1996;93:1238\u201342.","DOI":"10.1073\/pnas.93.3.1238"},{"key":"646_CR23","doi-asserted-by":"crossref","unstructured":"Lang T, Hitzl M, Burk O, Mornhinweg E, Keil A, et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP 3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics. 2004;14:155\u201364.","DOI":"10.1097\/00008571-200403000-00003"},{"key":"646_CR24","doi-asserted-by":"crossref","unstructured":"Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, et al. Generation of novel pharmacogenomic candidates in the response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics. 2010;20:665\u201376.","DOI":"10.1097\/FPC.0b013e32833f2cd0"},{"key":"646_CR25","doi-asserted-by":"crossref","unstructured":"de Rotte MC, Bulatovic M, Heijstek MW, Jansen G, Heil SG, et al. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. J Rheumatol. 2012;39(10):2032\u201340.","DOI":"10.3899\/jrheum.111593"},{"issue":"1","key":"646_CR26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/art.30080","volume":"63","author":"ML Becker","year":"2011","unstructured":"Becker ML, Gaedick R, van Haandel L, Thomas B, Lasky A. The effect of genotype on methotrexate polyglumate variability in juvenile idiopathic arthritis and association with drug response. Arthritis Rheum. 2011;63(1):276\u201385.","journal-title":"Arthritis Rheum"},{"key":"646_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0814-z","author":"AF Hawwa","year":"2015","unstructured":"Hawwa AF, AlBawab A, Rooney M, Wedderburn LR, Beresford MW, et al. Methotrexate polyglumates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: and observational, cross-sectional study. Arthritis Res Ther. 2015. doi: 10.1186\/s13075-015-0814-z .","journal-title":"Arthritis Res Ther"},{"key":"646_CR28","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/art.20460","volume":"50","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004;50:2766\u201374.","journal-title":"Arthritis Rheum"},{"key":"646_CR29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","volume":"61","author":"HM Albers","year":"2009","unstructured":"Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheumatol. 2009;61:46\u201351.","journal-title":"Arthritis Rheumatol"},{"key":"646_CR30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/annrheumdis-2011-200942","volume":"71","author":"M Bulatovic","year":"2012","unstructured":"Bulatovic M, Hejistek MW, Van Dijkhuizen EH, Wulffraat NM, et al. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. Ann Rheum Dis. 2012;71:1484\u20139.","journal-title":"Ann Rheum Dis"},{"key":"646_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0071-y","author":"A Scheuern","year":"2016","unstructured":"Scheuern A, Fischer N, McDonald J, Brunner H, Johannes-Peter H, et al. Mutations in MTHFR gene are not associated with methotrexate intolerance in patients with juvenile idiopathic arthritis. Pediatr Rheumatol. 2016. doi: 10.1186\/s12969-016-0071-y .","journal-title":"Pediatr Rheumatol"},{"key":"646_CR32","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.30367","volume":"63","author":"M Bulatovic","year":"2011","unstructured":"Bulatovic M, Heijstek MW, Verkaaik M, van Dijkhulzen EH, Armbrust W, et al. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis. Development and validation of methotrexate intolerance severity score. Arthritis Rheum. 2011;63:2007\u201313.","journal-title":"Arthritis Rheum"},{"key":"646_CR33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet. 2010;42:1118\u201325.","journal-title":"Nat Genet"},{"key":"646_CR34","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00296-013-2714-3","volume":"33","author":"SH El-Hini","year":"2013","unstructured":"El-Hini SH, Mohamed FI, Hassan AA, Ali F, Mahmoud A. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int. 2013;33:2283\u20139.","journal-title":"Rheumatol Int"},{"key":"646_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cts.12399","volume":"9","author":"RS Funk","year":"2016","unstructured":"Funk RS, Singh R, Pramann L, Gigliotti N, Islam S. Nicotinamide phosphoribosyltransferase attenuates methotrexate response in juvenile idiopathic arthritis and in vitro. Clin Transl Sci. 2016;9:149\u201357.","journal-title":"Clin Transl Sci"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-017-0646-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:15:22Z","timestamp":1526642122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-017-0646-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1007\/s11926-017-0646-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2017,3,30]]},"article-number":"19"}}